Michel Detheux

Companies

• Vor Biopharma Inc.Board member Jul 18, 2025 to now¹
• iTeos Therapeutics, Inc.Board member Jul 23, 2020 to now²
• iTeos Therapeutics, Inc.Chief executive officer Jul 23, 2020 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ITiTeos Therapeutics, Inc.0 shares³Aug 29, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 29, 2025U 94,027 shares of iTeos Therapeutics, Inc.³
• Aug 29, 2025U 153,903 shares of iTeos Therapeutics, Inc.³
• Jun 10, 2025Exercised options 94,027 shares at $4.30 of iTeos Therapeutics, Inc.⁴
• Jun 10, 2025Exercised options 18,000 shares at $4.30 of iTeos Therapeutics, Inc.⁴
• Jun 10, 2025Sold 43,883 shares at $10.02 of iTeos Therapeutics, Inc.⁴
• Jun 10, 2025Exercised options 43,883 shares at $4.30 of iTeos Therapeutics, Inc.⁴
• Jun 10, 2025Sold 8,400 shares at $10.02 of iTeos Therapeutics, Inc.⁴
• Jun 10, 2025Exercised options 8,400 shares at $4.30 of iTeos Therapeutics, Inc.⁴
• Jun 9, 2025Sold 43,882 shares at $10.03 of iTeos Therapeutics, Inc.⁴
• Jun 9, 2025Exercised options 43,882 shares at $4.30 of iTeos Therapeutics, Inc.⁴
• Jun 9, 2025Sold 8,400 shares at $10.03 of iTeos Therapeutics, Inc.⁴
• Jun 9, 2025Exercised options 8,400 shares at $4.30 of iTeos Therapeutics, Inc.⁴
• Jun 6, 2025Sold 43,882 shares at $10.21 of iTeos Therapeutics, Inc.⁵
• Jun 6, 2025Exercised options 43,882 shares at $4.30 of iTeos Therapeutics, Inc.⁵
• Jun 6, 2025Sold 8,400 shares at $10.21 of iTeos Therapeutics, Inc.⁵
• Jun 6, 2025Exercised options 8,400 shares at $4.30 of iTeos Therapeutics, Inc.⁵
• Jun 5, 2025Sold 43,882 shares at $10.15 of iTeos Therapeutics, Inc.⁵
• Jun 5, 2025Exercised options 43,882 shares at $4.30 of iTeos Therapeutics, Inc.⁵
• Jun 5, 2025Sold 8,400 shares at $10.15 of iTeos Therapeutics, Inc.⁵
• Jun 5, 2025Exercised options 8,400 shares at $4.30 of iTeos Therapeutics, Inc.⁵
• Jun 4, 2025Sold 43,883 shares at $10.10 of iTeos Therapeutics, Inc.⁵
• Jun 4, 2025Exercised options 43,883 shares at $4.30 of iTeos Therapeutics, Inc.⁵
• Jun 4, 2025Sold 8,400 shares at $10.10 of iTeos Therapeutics, Inc.⁵
• Jun 4, 2025Exercised options 8,400 shares at $4.30 of iTeos Therapeutics, Inc.⁵
• Mar 7, 2025Granted 77,000 shares of iTeos Therapeutics, Inc.⁶